Search research articles
Contact Us
Filters
Showing results (41-50 of 47) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 47 results.
Cancer Research
|
October 6, 2005
Overexpression of LAMP3/TSC403/DC-LAMP promotes metastasis in uterine cervical cancer
Hiroyuki Kanao, Takayuki Enomoto, Toshihiro Kimura, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 21, 2009
Novel benzoylpiperidine-based stearoyl-CoA desaturase-1 inhibitors: Identification of 6-[4-(2-methylbenzoyl)piperidin-1-yl]pyridazine-3-carboxylic acid (2-hydroxy-2-pyridin-3-ylethyl)amide and its plasma triglyceride-lowering effects in Zucker fatty rats
Yoshikazu Uto, Tsuneaki Ogata, Yohei Kiyotsuka, et al.
American Journal of Clinical Pathology
|
August 25, 2004
Analysis of clonality and HPV infection in benign, hyperplastic, premalignant, and malignant lesions of the vulvar mucosa
Yutaka Ueda, Takayuki Enomoto, Takashi Miyatake, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 17, 2009
Novel spiropiperidine-based stearoyl-CoA desaturase-1 inhibitors: Identification of 1'-{6-[5-(pyridin-3-ylmethyl)-1,3,4-oxadiazol-2-yl]pyridazin-3-yl}-5-(trifluoromethyl)-3,4-dihydrospiro[chromene-2,4'-piperidine]
Yoshikazu Uto, Yohei Kiyotsuka, Yuko Ueno, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 23, 2009
Novel and potent inhibitors of stearoyl-CoA desaturase-1. Part II: Identification of 4-ethylamino-3-(2-hydroxyethoxy)-N-[5-(3-trifluoromethylbenzyl)thiazol-2-yl]benzamide and its biological evaluation
Yoshikazu Uto, Tsuneaki Ogata, Yohei Kiyotsuka, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 23, 2009
Novel and potent inhibitors of stearoyl-CoA desaturase-1. Part I: Discovery of 3-(2-hydroxyethoxy)-4-methoxy-N-[5-(3-trifluoromethylbenzyl)thiazol-2-yl]benzamide
Yoshikazu Uto, Tsuneaki Ogata, Jun Harada, et al.
Cancer Letters
|
February 7, 2006
Prognostic significance of p53 mutation in suboptimally resected advanced ovarian carcinoma treated with the combination chemotherapy of paclitaxel and carboplatin
Yuko Ueno, Takayuki Enomoto, Yoshiro Otsuki, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 47) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 47 results.
Cancer Research
|
October 6, 2005
Overexpression of LAMP3/TSC403/DC-LAMP promotes metastasis in uterine cervical cancer
Hiroyuki Kanao, Takayuki Enomoto, Toshihiro Kimura, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 21, 2009
Novel benzoylpiperidine-based stearoyl-CoA desaturase-1 inhibitors: Identification of 6-[4-(2-methylbenzoyl)piperidin-1-yl]pyridazine-3-carboxylic acid (2-hydroxy-2-pyridin-3-ylethyl)amide and its plasma triglyceride-lowering effects in Zucker fatty rats
Yoshikazu Uto, Tsuneaki Ogata, Yohei Kiyotsuka, et al.
American Journal of Clinical Pathology
|
August 25, 2004
Analysis of clonality and HPV infection in benign, hyperplastic, premalignant, and malignant lesions of the vulvar mucosa
Yutaka Ueda, Takayuki Enomoto, Takashi Miyatake, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 17, 2009
Novel spiropiperidine-based stearoyl-CoA desaturase-1 inhibitors: Identification of 1'-{6-[5-(pyridin-3-ylmethyl)-1,3,4-oxadiazol-2-yl]pyridazin-3-yl}-5-(trifluoromethyl)-3,4-dihydrospiro[chromene-2,4'-piperidine]
Yoshikazu Uto, Yohei Kiyotsuka, Yuko Ueno, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 23, 2009
Novel and potent inhibitors of stearoyl-CoA desaturase-1. Part II: Identification of 4-ethylamino-3-(2-hydroxyethoxy)-N-[5-(3-trifluoromethylbenzyl)thiazol-2-yl]benzamide and its biological evaluation
Yoshikazu Uto, Tsuneaki Ogata, Yohei Kiyotsuka, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 23, 2009
Novel and potent inhibitors of stearoyl-CoA desaturase-1. Part I: Discovery of 3-(2-hydroxyethoxy)-4-methoxy-N-[5-(3-trifluoromethylbenzyl)thiazol-2-yl]benzamide
Yoshikazu Uto, Tsuneaki Ogata, Jun Harada, et al.
Cancer Letters
|
February 7, 2006
Prognostic significance of p53 mutation in suboptimally resected advanced ovarian carcinoma treated with the combination chemotherapy of paclitaxel and carboplatin
Yuko Ueno, Takayuki Enomoto, Yoshiro Otsuki, et al.
Page
of 5